PMID- 16004027
OWN - NLM
STAT- MEDLINE
DCOM- 20060109
LR  - 20131121
IS  - 1545-9616 (Print)
IS  - 1545-9616 (Linking)
VI  - 4
IP  - 4
DP  - 2005 Jul-Aug
TI  - Case report: verapamil-induced subacute cutaneous lupus erythematosus.
PG  - 506-8
AB  - Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, 
      are one of the most widely prescribed class of drugs in the treatment of 
      cardiovascular disease. In the last several years, CCBs have been linked with a 
      distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus 
      erythematosus (SCLE), and we describe a case induced by verapamil.
FAU - Kurtis, Boaz
AU  - Kurtis B
AD  - Department of Medicine, St. Luke's-Roosevelt Hospital Center, New York, NY, USA.
FAU - Larson, Matthew J
AU  - Larson MJ
FAU - Hoang, Mai P
AU  - Hoang MP
FAU - Cohen, Jack B
AU  - Cohen JB
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - J Drugs Dermatol
JT  - Journal of drugs in dermatology : JDD
JID - 101160020
RN  - CJ0O37KU29 (Verapamil)
SB  - IM
MH  - Female
MH  - Humans
MH  - Lupus Erythematosus, Cutaneous/*chemically induced/*pathology
MH  - Middle Aged
MH  - Verapamil/*adverse effects
EDAT- 2005/07/12 09:00
MHDA- 2006/01/10 09:00
CRDT- 2005/07/12 09:00
PHST- 2005/07/12 09:00 [pubmed]
PHST- 2006/01/10 09:00 [medline]
PHST- 2005/07/12 09:00 [entrez]
PST - ppublish
SO  - J Drugs Dermatol. 2005 Jul-Aug;4(4):506-8.